Page last updated: 2024-10-21

tacrine and Leukemia

tacrine has been researched along with Leukemia in 1 studies

Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Janočková, J1
Plšíková, J1
Koval', J1
Jendželovský, R1
Mikeš, J1
Kašpárková, J1
Brabec, V1
Hamuľaková, S1
Fedoročko, P1
Kožurková, M1

Other Studies

1 other study available for tacrine and Leukemia

ArticleYear
Tacrine derivatives as dual topoisomerase I and II catalytic inhibitors.
    Bioorganic chemistry, 2015, Volume: 59

    Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; DNA; DNA Topoisomerases; HL-60 Cells; Humans;

2015